ARTICLE | Company News
Valeant Pharmaceuticals sales and marketing update
September 12, 2016 7:00 AM UTC
Valeant launched an oral formulation of Relistor methylnaltrexone in the U.S. to treat opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain. The wholesale acquisition cost...